MarketCap
Facebook
X
TelegramGeschäftsbericht 2024
hinzugefügt 11.04.2026
Land |
 Frankreich |
IPO-Jahr |
2019 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
- |
Marktkapitalisierung |
$ 160 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
Aligos Therapeutics
ALGS
|
$ 8.48 | 6.0 % | $ 83.8 M | Nasdaq Global Select Market |  USA |
 |
Alterity Therapeutics Limited
ATHE
|
$ 3.66 | -1.48 % | $ 8.81 B | Nasdaq Capital Market |  Australia |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | USA |
 |
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market | France |
 |
Esperion Therapeutics
ESPR
|
$ 2.19 | 0.92 % | $ 455 M | Nasdaq Global Market,SPB | USA |
 |
Evogene Ltd.
EVGN
|
$ 0.78 | -4.39 % | $ 27.9 M | Nasdaq Global Market |  Israel |
 |
Applied Therapeutics
APLT
|
- | - | $ 8.42 M | Nasdaq Global Market,SPB | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market |  Britain |
 |
Genmab A/S
GMAB
|
$ 28.2 | -0.18 % | $ 18 B | Nasdaq Global Select Market |  Danmark |
 |
Grifols, S.A.
GRFS
|
$ 8.38 | 2.01 % | $ 6.83 B | Nasdaq Global Select Market |  Spain |
 |
GT Biopharma
GTBP
|
$ 0.38 | 2.47 % | $ 2.1 M | Nasdaq Capital Market | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
$ 21.28 | 4.44 % | $ 995 M | Nasdaq Global Select Market | USA |
 |
Halozyme Therapeutics
HALO
|
$ 66.92 | -1.33 % | $ 8.02 B | Nasdaq Global Select Market,SPB | USA |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Harmony Biosciences Holdings
HRMY
|
$ 29.05 | 0.55 % | $ 1.67 B | Nasdaq Global Select Market | USA |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market |  Canada |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
|
Immatics N.V.
IMTX
|
$ 10.87 | 4.17 % | $ 684 M | Nasdaq Global Select Market | Germany |
 |
Incyte Corporation
INCY
|
$ 95.33 | -0.77 % | $ 18.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
Akebia Therapeutics
AKBA
|
$ 1.46 | 4.29 % | $ 375 M | Nasdaq Global Market | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 2.99 | 2.4 % | $ 4.92 M | NYSE American | Israel |
 |
Aptinyx
APTX
|
- | -39.0 % | $ 4.57 M | Nasdaq Global Select Market | USA |
 |
Aquestive Therapeutics
AQST
|
$ 4.2 | 2.82 % | $ 449 M | Nasdaq Global Market | USA |
 |
Aravive
ARAV
|
- | -13.39 % | $ 1.45 M | Nasdaq Global Select Market | USA |
 |
Arcutis Biotherapeutics
ARQT
|
$ 24.24 | 0.1 % | $ 3.08 B | Nasdaq Global Select Market,SPB | USA |
 |
Innate Pharma S.A.
IPHA
|
$ 1.47 | 4.26 % | $ 235 M | Nasdaq Global Select Market | France |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Celldex Therapeutics
CLDX
|
$ 32.59 | 1.09 % | $ 2.16 B | Nasdaq Global Select Market | USA |
 |
Autolus Therapeutics plc
AUTL
|
$ 1.48 | -0.67 % | $ 394 M | Nasdaq Global Select Market | Britain |
 |
Aptose Biosciences
APTO
|
- | -45.71 % | $ 1.2 M | Nasdaq Capital Market | Canada |
 |
Cidara Therapeutics
CDTX
|
- | - | $ 1.41 B | Nasdaq Global Market | USA |
 |
AVROBIO
AVRO
|
- | 1083.1 % | $ 745 M | Nasdaq Global Select Market | USA |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market | Israel |
 |
AstraZeneca PLC
AZN
|
- | - | $ 96.9 B | Nasdaq Global Select Market | Britain |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | Germany |
 |
Brainstorm Cell Therapeutics
BCLI
|
- | -2.5 % | $ 5.88 M | Nasdaq Capital Market | USA |
 |
BeiGene, Ltd.
BGNE
|
- | 0.49 % | $ 251 B | Nasdaq Global Select Market |  Cayman-islands |